Aniridia is a rare, vision-threatening condition defined by partial or complete hypoplasia of the iris. It is a serious genetic disorder associated with the abnormal development of the iris of the ...

Q: How does aniridia affect vision? A: Aniridia affects vision through multiple mechanisms, which include development of keratopathy, cataract, glaucoma, retinal tears and retinal detachment.

The medical records of 56 patients with aniridia (31 female, 25 male, mean age 33 years, range 2–74 years) were retrospectively evaluated for optic nerve and foveal hypoplasia. The difference in ...

You may never have heard of aniridia, a genetic disorder that robs people of their vision. But researchers studying the condition say it could give insight into some common health problems – from ...

When I was seven years old, an ophthalmologist told me that I was born with aniridia. It is an eye disorder characterized by a complete or partial absence of the iris (colored part of the eye). This ...

The future for Abbie-Rosie and Chris seems ever more hopeful. Both are carefully monitored for glaucoma and cataracts which often go hand in hand with Aniridia making their prognosis more hopeful.

ATHENS — Deep anterior lamellar keratoplasty with amniotic membrane graft is an effective option for restoring corneal clarity and visual acuity for patients with aniridia keratopathy ...

Congenital aniridia, a rare genetic disorder in which the iris is completely or partially absent, affects about 1 in 50,000 to 100,000 people in the United States.

Congenital aniridia was recorded for 6 of the children; the rate among patients with Wilms's tumor, 1:73, is markedly greater than the at-birth incidence of 1:50,000 estimated by Shaw, Falls and ...

VIENNA —In this Healio Video Perspective from the ESCRS meeting, Matteo Forlini, MD, speaks about a new method to simultaneously correct aniridia and aphakia in post-traumatic cases.

Aniridia is a rare, genetic disorder in which the iris is partially or completely missing or damaged. It affects approximately 1 in 50,000 to 100,000 people in the US and can severely affect vision.